Showing results (111-120 of 175) with videos related to

Sort By:
Pageof 18
Journal of Cancer Research and Therapeutics|September 23, 2022
Laparoscopic-assisted surgery versus open surgery for transverse colon cancer: A multicenter retrospective studyHiroshi Tamagawa, Masakatsu Numata, Toru Aoyama, et al.
Anticancer Research|January 2, 2020
Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and RecurrenceToru Aoyama, Keisuke Kazama, Yosuke Atsumi, et al.
Anticancer Research|April 3, 2020
Postoperative Bleeding After Esophagectomy for Esophageal Cancer in Patients Receiving Antiplatelet and Anticoagulation TreatmentToru Aoyama, Yosuke Atsumi, Kentaro Hara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 22, 2019
[A Case of Early-Developing Rapidly Progressive Glomerulonephritis after Laparoscopic-Assisted Distal Gastrectomy for Gastric Cancer]Atsuhiko Sugiyama, Toru Aoyama, Kazuya Endo, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 22, 2019
[A Case of Malignant Peritoneal Mesothelioma Resected Four Times in Five Years]Daishi Takahashi, Toru Aoyama, Masakatsu Numata, et al.
In Vivo (Athens, Greece)|June 27, 2024
The Systemic Immune-inflammation Index Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Anticancer Research|August 1, 2018
The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant ChemotherapyToru Aoyama, Naoto Yamamoto, Mariko Kamiya, et al.
Anticancer Research|April 30, 2022
Impact of Infectious Complications on Survival and Recurrence of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective StudyHiroshi Tamagawa, Toru Aoyama, Masakatsu Numata, et al.
Anticancer Research|March 6, 2020
The Prognostic Value of the Perioperative Systemic Inflammation Score for Patients With Advanced Gastric CancerKentaro Hara, Toru Aoyama, Takanobu Yamada, et al.
Journal of Cancer Research and Therapeutics|December 31, 2020
The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuvant chemotherapyToru Aoyama, Naoto Yamamoto, Mariko Kamiya, et al.
Pageof 18